Participating with me today are CEO Jon Stonehouse; CFO Anthony Doyle; Chief Commercial Officer Charlie Gayer; and Chief R&D Officer Dr. Helen Thackray. Following our remarks, we'll answer your ...
and our pediatric label expansion for ORLADEYO anticipated later this year,” said Jon Stonehouse, president and chief executive officer of BioCryst. Program Updates and Key Milestones ORLADEYO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback